| 3TM9 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | EDO, HEM | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Crystallographic structure determination of B10 mutants of Vitreoscilla hemoglobin: role of Tyr29 (B10) in the structure of the ligand-binding site., Ratakonda S, Anand A, Dikshit K, Stark BC, Howard AJ, Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Mar 1;69(Pt 3):215-22., doi: 10.1107/S1744309112044818. Epub 2013 Feb 22. PMID:23519792 | ||||||||||||||
| Data retrieval |
![]() |
| View 3TM9 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |